Grace Covenant, November 1st - China Regenerative Medicine (08158.HK) announced that on November 1, 2024, the company's wholly owned subsidiary HKIRC and CRMI (Hong Kong) (as tenant) entered into a lease agreement with independent third party Zhengxin (as landlord), accordingly, Zhengxin agreed to lease the property to the company.
中国再生医学(08158.HK)与正信订立租赁协议
CRMI (08158.HK) signed a leasing agreement with Positron.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.